Skip to content
Magnolia Medical
Our Products
Healthcare Professionals
Blood Cultures
About
Contact Us

News & Media

View All News Press Release Webinars Videos Blog Media Events Case Study
Newly Released CLSI National Blood Culture Guidelines Identify Best Practices and Evidence-Based Technology Solutions Such as Steripath ® to Improve Patient Safety and Outcomes

Newly Released CLSI National Blood Culture Guidelines Identify Best Practices and Evidence-Based Technology Solutions Such as Steripath ® to Improve Patient Safety and Outcomes

May 5, 2022
Standardized Techniques for a New Standard in Blood Culture Contamination

Standardized Techniques for a New Standard in Blood Culture Contamination

April 26, 2022
Novel Study Demonstrates the Hospital-Wide Impact of the Steripath® Initial Specimen Diversion Device® on Blood Culture Contamination Rates and Sepsis Testing Accuracy at WVU United Hospital Center

Novel Study Demonstrates the Hospital-Wide Impact of the Steripath® Initial Specimen Diversion Device® on Blood Culture Contamination Rates and Sepsis Testing Accuracy at WVU United Hospital Center

April 6, 2022
Magnolia Medical Announces $46 Million Growth Equity Financing

Magnolia Medical Announces $46 Million Growth Equity Financing

February 16, 2022
Magnolia Medical, MHA Solutions, and Healthcare Providers Insurance Company Enter into an Exclusive, Endorsed Agreement for the Steripath® Initial Specimen Diversion Device®

Magnolia Medical, MHA Solutions, and Healthcare Providers Insurance Company Enter into an Exclusive, Endorsed Agreement for the Steripath® Initial Specimen Diversion Device®

December 15, 2021
Members of Congress Urge CMS to Take Action to Reduce Preventable False-Positive Diagnostic Test Results for Sepsis

Members of Congress Urge CMS to Take Action to Reduce Preventable False-Positive Diagnostic Test Results for Sepsis

December 8, 2021

We use our own and third-party cookies to personalize content and to analyze web traffic.

Read our privacy policy